A bdominal aortic aneurysms (AAAs) occur in Ϸ3% of humans Ͼ65 years of age and are characterized by localized structural deterioration of the aortic wall, leading to progressive aortic dilation. The most dreaded complication of AAA is rupture, the likelihood of which is directly related to aneurysm diameter. 1 Although open surgical repair can improve outcomes in patients with large AAAs, the procedure is associated with significant operative risks and complications, particularly in the presence of comorbid conditions common in these patients. Percutaneous repair techniques (ie, stent grafting) have been developed, but not all patients are candidates, and these procedures are also associated with significant complications. 2 The development of effective medical therapy for AAA has been hampered by lack of understanding of the mechanisms responsible for aneurysm growth and rupture.
Studies published over the past decade support the view that inflammation plays a key role in the pathogenesis of AAAs. [3] [4] [5] [6] [7] One of the known causes and consequences of inflammation is an increase in local levels of oxidative stress.
Indeed, Miller et al have shown that human aneurysmal aorta displays clear evidence of increased oxidative damage and pro-oxidant enzyme expression/activity compared with adjacent nonaneurysmal tissue. 8 Whether oxidative stress is merely associated with AAAs, or whether it contributes to the pathogenesis of the disease, remains to be determined.
In the present study, we examined the effects of vitamin E, a dietary antioxidant with proven efficacy in mice, in the murine angiotensin II (Ang II) infusion AAA model. In this model, infusion of Ang II for 4 weeks in apolipoprotein E (apoE)-deficient male mice results in formation of AAAs in 90% to 100% of these animals. 9, 10 We demonstrate that vitamin E has a marked impact on both aneurysm formation and its consequences (ie, rupture). These findings are consistent with the view that oxidative stress contributes to the pathophysiology of AAAs.
(placebo control), Ang II (1000 ng/kg per minute), or Ang II plus dietary vitamin E (2 IU/g of diet). The experimental protocol was approved by the Institutional Animal Care and Use Committee at the University of Iowa and the Iowa City Veterans Administration Medical Center. For detailed methodologies [11] [12] [13] [14] of the various determinations, including statistical analysis, please see the online data supplement available at http://atvb.ahajournals.org.
Results

Vitamin E Did Not Affect Systolic Blood Pressure or Lipid Profile in This Experimental Model
As hypertension is a documented risk factor for AAA enlargement and is induced by Ang II, we monitored this parameter in both control and treated apoE-deficient mice. Ang II infusion significantly increased systolic blood pressure (SBP), from a baseline of 106 mm Hg to 140 to 150 mm Hg (Table) , within 48 hours after Ang II infusion, and persisted essentially unchanged throughout the study. No significant differences in SBP were observed at any time point between control and vitamin E-supplemented animals. Moreover, there was no correlation between SBP and either mortality or size of AAA (data not shown).
All animals developed severe hyperlipidemia, as expected in apoE-deficient mice (mean cholesterol, 789Ϯ51 mg/dL); however, neither infusion of Ang II nor dietary supplementation with vitamin E significantly affected the levels of total cholesterol or triglycerides determined at the conclusion of the study (Table) . As evidence of the effectiveness of the vitamin E diet, we observed an Ϸ3-fold increase in plasma vitamin E levels in Ang II-infused mice supplemented with the vitamin E diet (Ang II only, 4.04Ϯ1.63 mg/L; Ang IIϩvitamin E, 12.26Ϯ5.59 mg/L; PϽ0.05, nϭ5, meanϮSD).
Vitamin E Decreased AAA Diameter and Weight
After 4 weeks of Ang II or saline infusion, animals were euthanized, and aortae were isolated and examined for the presence of AAA. As previously reported, aneurysms of the suprarenal abdominal aorta were present in 90% of Ang II-treated mice (no vitamin E), whereas no saline-infused (control) animals developed AAAs. 10 Twenty percent of animals infused with Ang II only developed lower thoracic aorta aneurysms in addition to the AAAs. Periaortic inflammation was a prominent feature in animals that developed aneurysms, as evidenced by densely adherent periadventitial tissue that required microdissection to delineate the wall of the abdominal aorta.
Animals that received dietary vitamin E in addition to Ang II infusion showed a 24% reduction in maximal aortic diameter (PϽ0.05) and a 34% reduction in abdominal aortic weight (PϽ0.05) as compared with animals that received Ang II only ( Figure 1A ). The incidence of AAA formation in animals treated with vitamin E during infusion of Ang II was 60%. Lower thoracic aorta aneurysms were not observed in any Ang II-infused animals treated with vitamin E. Representative aortae from these mice are shown in Figure 1B . For comparison purposes, an aorta from a control mouse (salineinfused) is also shown. SBP was measured using a computerized tail-cuff system 1 week before (pre-Ang II) and throughout the duration of Ang II infusion (nϭ10 for each). Lipid analysis was performed at the end of the study (control, nϭ3; Ang II and Ang IIϩvitamin E, nϭ6). All results are expressed as meanϮSEM. *PϽ0.05 compared with control. vitE indicates vitamin E. 
Vitamin E Decreased the Incidence of Fatal Plus Nonfatal AAA Rupture
We have defined aneurysm rupture as either (1) presence of thrombus detected visibly or by dissection microscopy (Figure 1B) or (2) microscopic confirmation of elastin band rupture with associated dissection and microthrombus formation in the vascular wall ( Figure 2A ). When these microscopic ruptures evolve into a complete rupture of the aortic wall, the result is death. Accordingly, all animals that died in the course of this study (before termination at 4 weeks) were determined to have aortic rupture at the time of necropsy. Each of these animals died unexpectedly, without premonitory signs of infection or other chronic illnesses. There were no deaths or aortic ruptures in saline-infused mice. Of the Ang II-infused animals consuming a regular diet, 44.5% died before the end of the study (fatal rupture, Figure 2B ), 44.5% survived until the end of the study but had evidence of aortic rupture (nonfatal rupture, Figure 2B ), and 11% survived with no detectable rupture. In contrast, of the animals infused with Ang II and cotreated with vitamin E, 17% died before the end of the study, 33% survived but had evidence of aortic rupture, and 50% survived with no detectable rupture. Thus, in Ang II-infused animals consuming a regular diet (nϭ18), the combined incidence of fatalϩnonfatal rupture was 89%. Cotreatment with vitamin E (nϭ12) resulted in a 44% reduction in this combined end point (PϽ0.05 versus Ang II alone) ( Figure 2B ).
Vitamin E Did Not Affect Development of Atherosclerosis at the Aortic Root
Because atherosclerosis is frequently observed in AAA patients, and because previous studies have reported that vitamin E can attenuate atherosclerosis formation in hyperlipidemic mice in the absence of Ang II infusion, 15, 16 we investigated whether vitamin E treatment modulated atherosclerosis of the aortic root in our experimental model. It is important to note that only those animals that survived for the duration of the study were included in this analysis. We found that Ang II induced a small, statistically insignificant, increase in the extent of aortic root atherosclerosis ( Figure I , available online at http://atvb.ahajournals.org), which was not affected by concurrent dietary vitamin E supplementation.
Vitamin E Decreased Formation of 8-Isoprostane in Abdominal Aorta
To examine whether vitamin E exerted an antioxidant effect in the abdominal aorta during AAA formation, we determined the concentration of 8-isoprostanes in aortic tissue homogenates. 8-Isoprostanes are stable products of membrane lipid peroxidation, and their tissue concentration correlates with the level of oxidative stress. 17 Ang II treatment resulted in a Ͼ3-fold increase in 8-isoprostane content in the abdominal aorta, which was markedly attenuated by dietary vitamin E supplementation (PϽ0.05; Figure 3 ). This observed decrease in 8-isoprostane formation is consistent with vitamin E providing antioxidant protection in the tissue where AAA develops.
Vitamin E Decreased Macrophage Infiltration of the Aneurysmal Tissue
Inflammation plays an essential role in AAA, and macrophage infiltration is a critical part of the inflammatory process. Moreover, dietary vitamin E has been shown to reduce macrophage infiltration in the aortic root of hyperlipidemic mice. 16 To determine whether vitamin E reduced tissue macrophage infiltration in AAA, serial tissue blocks prepared at the same distance from the point of maximal aortic diameter were examined. Two blinded investigators assigned a quantitative score to both the intensity of the macrophage staining (0 to 3) and to the percentage of area that stained positive for macrophages (0% to 100%). An index of macrophage infiltration was calculated by multiplying the 2 scores. We were thus able to demonstrate a 43% reduction in the macrophage infiltration index with vitamin E treatment (PϽ0.05) ( Figure 4A ). In AAA tissues, the macrophage staining appeared to be much more prominent in the adventitia than in the media ( Figure 4C and 4D ). This is consistent with a recently published chronological study of AAA histology in the same animal model, 18 where macrophage infiltration was first noted in the media of the abdominal aorta soon after initiation of Ang II infusion and became more prominent in the adventitia at later time points.
Effects of Vitamin E on Matrix Metalloproteinase 2 and Metalloproteinase 9 Activity, and Osteopontin Expression, in AAA
Because matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, play a critical role in AAA formation, 19 and because the activity of MMPs may, in part, be redox regulated, 20 we examined MMP gelatinolytic activity in abdominal aortic tissue homogenates. As expected, Ang II infusion induced an increase in both MMP-2 and MMP-9 activity compared with control (saline infusion). Treatment with vitamin E, however, had no effect on either MMP-2 or MMP-9 activity in abdominal aortae of Ang II-infused mice ( Figure 5A and 5B).
We also investigated the potential for vitamin E to modulate aortic expression of osteopontin (OPN), a signaling protein first discovered in bone tissue and, more recently, shown to be involved in a variety of vascular diseases. Of interest to the present study, apoE-deficient mice that are also deficient in OPN are protected against Ang II-induced AAA formation, 21 suggesting that OPN expression plays an important role in AAA development in this model. Moreover, there is evidence that OPN expression may be redox regulated. 22 We found that in apoE-deficient mice, Ang II infusion induced a marked increase in OPN expression, as determined by Western blotting, which was significantly reduced by treatment with vitamin E (Figure 6A and 6B). Immunostaining showed that vitamin E reduced OPN expression in both the adventitia and media of aorta from Ang II-infused mice ( Figure 6C and 6D ).
Discussion
Here, we demonstrate for the first time that vitamin E exerts important protective effects against Ang II-induced AAA formation in apoE-deficient mice. Vitamin E led to a 44% decrease (PϽ0.05) in the clinically important combined end point of fatalϩnonfatal aortic rupture. Treatment with vitamin E also significantly decreased both the diameter and weight of AAAs in these mice. The reduction in aortic weight resulting from vitamin E treatment resulted, at least in part, from a diminution in the extent of macrophage infiltration and aortic rupture/thrombus formation. Although atherosclerotic lesions can affect the absolute aortic weight, there were no differences in the extent of atherosclerosis observed between the control and vitamin E groups. It should be emphasized that only animals surviving to the end of the 4-week infusion of Ang II were included in the analysis of AAA size. Furthermore, as rupture is an event linked to the size of the aneurysm, it is likely that the moderate reduction in AAA size produced by vitamin E therapy underestimates the true magnitude of its protective effect.
The murine Ang II-infusion model of AAA formation has attracted considerable interest for its potential relevance to human AAAs. 9, 10, [23] [24] [25] For example, the development of AAAs in this model is associated with hyperlipidemia (ie, reported to occur in apoE-deficient or low-density lipoprotein receptor-deficient mice) and male sex. 9 Also, histological features include leukocyte infiltration, medial degeneration, and thrombus formation, all of which are observed in human AAAs. 9 On the other hand, AAAs commonly form in the suprarenal aorta in the murine Ang II-infusion model, in contrast to the infrarenal aorta in humans. In addition, AAAs in humans are characterized by luminal dilation and wall thinning. Although luminal dilation has been demonstrated in the murine Ang II-infusion model by aortic ultrasonography in vivo and by pressure fixation techniques in vitro, thickening, rather than thinning, of the aortic wall is typically observed. 26 The wall thickening observed in the murine Ang II-infusion model is caused, in part, by hemorrhage into the aorta with associated thrombus formation, suggesting that the model may more closely resemble aortic dissection than common aneurysm formation in humans.
Several lines of evidence point to an increase in oxidative stress associated with AAA formation and/or progression. Using cDNA microarray analysis, Yajima et al detected upregulation of the expression of genes involved in oxidative stress in AAAs induced by elastase infusion in rats. 27 Nakahashi et al reported that parenteral supplementation with vitamin E in the rat elastase model reduced aortic enlargement and reactive oxygen species (ROS) production. 28 This latter study was conducted on a very small number of animals (just 3 rats were treated with vitamin E) and the efficacy of vitamin E to ameliorate clinical end points (ie, aneurysm rupture or mortality) was not examined. Human AAA tissues have also been reported to display evidence of increased oxidative stress. 8, 29 Moreover, plasma levels of vitamin E were markedly reduced in patients with AAAs but not in patients with coronary artery disease in the absence of AAAs. 30 Our group recently reported increased expression and activity of NADPH oxidase, an ROS generating enzyme, in human AAA as compared with adjacent nonaneurysmal aortic segments obtained from the same patients. 8 Notably, Ang II has been shown to induce aortic oxidative stress by activating NADPH oxidase. [31] [32] [33] [34] In total, these studies suggest that ROS generated through NADPH oxidase may play an important role in formation of AAAs in animal models and in humans.
Here, we demonstrated that Ang II infusion markedly increased aortic isoprostane formation, which was significantly lowered by treatment with dietary vitamin E, confirming that vitamin E effectively reduced aortic oxidative stress in this animal model. Furthermore, this decrease in aortic oxidative stress was associated with amelioration of AAA and its consequences. Notably, several clinical studies of antioxidants in humans have established a correlation between therapeutic efficacy and the capacity to ameliorate markers of oxidative stress. 35 However, we cannot exclude the possibility that the beneficial effects of vitamin E were attributable to mechanism(s) independent of its antioxidant properties. For example, vitamin E was shown to inhibit protein kinase C, 36 leading to impaired smooth muscle cell proliferation and diminished NADPH oxidase activity (which may indirectly reduce oxidative stress).
The data in this study provide some insight into the mechanisms by which oxidative stress might contribute to AAA formation in the Ang II-infusion model. First, Ang II is a potent inducer of superoxide, which contributes to the pressor response in mice. [31] [32] [33] [34] Hypertension is also an important factor in the genesis of AAAs in humans. However, treatment with vitamin E, which is not an efficient scavenger of superoxide, did not ameliorate Ang II-induced hypertension. This observation indicates that the mechanical forces produced by superoxide-induced hypertension are not solely responsible for induction of AAAs. Likewise, vitamin E did not affect lipid levels or attenuate atherosclerotic lesion formation. Together, these results suggest that oxidative stress most likely acts locally within the aortic wall to contribute to AAA formation in this model.
In vascular cells, Ang II is a potent inducer of chemotactic cytokines and adhesion molecules, which recruit inflammatory cells to vascular lesions. Histological studies have demonstrated infiltration of macrophages and other inflammatory cells into the aorta occurring in the very first days of Ang II infusion in hyperlipidemic mice, preceding the development of AAAs. 18 We demonstrated that vitamin E significantly reduced macrophage infiltration into the abdominal aorta of Ang II-infused animals, which likely contributed to its protective effects with regard to AAA size and the extent of aortic rupture. Moreover, we demonstrated that vitamin E treatment markedly attenuated Ang II-induced upregulation of aortic OPN, a chemotactic cytokine that was recently implicated in Ang II-induced AAA formation in this model. 21 In one previous study, ROS were reported to stimulate Ang II-induced OPN expression in cultured endothelial cells. 22 Our study extends these prior findings and suggests that redox regulation of OPN expression may be an important mechanism linking oxidative stress to vascular disease in vivo. It is important to point out that several other cytokines and adhesion molecules have been reported to be redoxregulated [37] [38] [39] and could potentially have been affected by treatment with vitamin E. However, unlike OPN, their role in AAA formation in this model has not been established.
Both resident smooth muscle cells and infiltrating inflammatory cells produce matrix metalloproteinases, in particular MMP-2 and MMP-9, which have been implicated in formation of AAAs, 19 and their activities may be stimulated by ROS. 20 We, therefore, investigated whether vitamin E treatment inhibited the activity of MMP-2 and/or MMP-9 in aortic tissues. As expected, Ang II infusion markedly increased MMP-2 and MMP-9 activity in whole aorta homogenates. This increase in MMP activity was not, however, inhibited by treatment with vitamin E. It is important to point out that the zymography was performed on equivalent amounts of aortic homogenates (determined by protein assay) from each group. Because the aortae from Ang II-treated mice were larger and contained more macrophages than those from mice treated with Ang IIϩvitamin E, it is likely that the absolute amount of MMP per aorta was, in fact, reduced by treatment with vitamin E. It is also possible that MMPs other than MMP-2 and -9 could be involved in Ang II-induced AAAs in this model. However, we did not see additional unidentified bands on the zymographs. Finally, the presence and/or activity of MMP inhibitors may differ between experimental groups. Additional studies are needed to address these possibilities.
Although vitamin E led to a significant decrease in AAAs, it did not attenuate atherosclerosis in the aortic root of Ang II-treated apoE-deficient mice. This is in contrast to previous studies reporting attenuation of atherosclerosis in hyperlipidemic mice treated with the same dose of vitamin E used in the present study. 15, 16 There are several potential explanations for this apparent discrepancy. The previous studies differed from the current study in dietary fat content, age, and genetic backgrounds of the mice, and the duration of vitamin E treatment. In addition, we quantified atherosclerosis only at the aortic root, and our findings are actually in agreement with some studies showing a lack of effect of vitamin E on atherosclerosis at this level. 40, 41 Most importantly, these prior studies were not performed on mice infused with Ang II, which is known to markedly increase the production of ROS.
In summary, we report that vitamin E protects against AAA formation in the murine Ang II-infusion model. These findings are consistent with the concept that oxidative stress may play a causal role in the pathogenesis of Ang II-driven AAAs in mice. Furthermore, these results suggest that additional basic and clinical research using vitamin E and other antioxidants is warranted to define the role of oxidative stress in the pathogenesis of AAAs.
Materials and Methods:
Experimental Animals. Six month old male apoE-deficient mice, backcrossed 10 times onto a C57BL/6 background, were procured from the Jackson Laboratory. After a minimum 48 hours acclimatization period, mice were randomly assigned to one of three groups: infusion of normal saline (placebo control), infusion of ANGII (1000 ng/ kg/min), or infusion of ANGII plus dietary vitamin E at a dose of 2 IU/gm of diet (Research Diets, Inc.). Vitamin E supplemented diet was initiated 1 week prior to the ANGII infusion and continued throughout the duration of the study.
After 4 weeks, mice were euthanized, aortic diameter was measured as described below, blood was drawn for lipid analysis, and aortic tissue was harvested, weighed, and processed for histology and/or biochemical studies. Plasma vitamin E levels were determined by HPLC 1 (ARUP Laboratories Inc., Salt Lake City, UT) For this study, AAA was defined as ≥ 50% enlargement of maximal abdominal aorta diameter.
Necropsy was performed as soon as possible on the animals that expired prior to completion of the study. To exclude artifactual results due to tissue degradation, these animals were not included in the histological or AAA quantification analysis, but only in the mortality data. The Aortic tissue collection and measurement. After animals were euthanized, the abdominal and thoracic cavities were entered, blood was drawn from the right ventricle, and the aorta was irrigated with cold PBS at physiologic pressure through the left ventricle. Using a dissection microscope (Olympus SZ-CTV), the abdominal aorta was exposed, and the peri-adventitial tissue was carefully dissected away from the wall of the aorta. Maximal aortic diameter was then determined with a digital caliper (Mitutoyo Absolute Digimatic). The aortic root and heart were subsequently dissected out as described previously 2 . The abdominal aorta (from the last intercostal artery to the ileal bifurcation) was sectioned, weighed, and either preserved at -80°C with 0.005% butylated hydroxytoluene (BHT) (for 8-isoprostane assay) or fixed in 4% paraformaldehyde (for histology and immunohistochemistry). were measured by zymography as previously described 3 . Briefly, pre-poured 10% polyacrylamide gels containing 1 mg/ml gelatin A were purchased from Bio-Rad. Equivalent amounts of samples were loaded based on protein content (Bradford assay; Bio-Rad). After electrophoresis, the gels were washed twice in a buffer containing 2.5% Triton X-100 and 50
Determination of aortic 8-isoprostane content by enzyme immunoassay (EIA
mM Tris-HCl (pH 8.0) for 30 min. The gels were then incubated overnight with a developing buffer containing 50 mM Tris, 10 mM CaCl 2 , and 50 mM NaCl at 37°C, then stained with
Coomassie Blue, and analyzed using an Alpha-Innotech densitometer with AlphaImager V5.5
software.
Western Blotting. Western blotting for OPN was performed as previously described 4 . Briefly, pre-poured 10% polyacrylamide gels (Bio-Rad) were loaded with equal protein amounts of whole mouse aortic homogenates (Bradford assay; Bio-Rad), electrophoresed, and transferred to nitrocellulose. Primary antibody against OPN was obtained from University of Iowa Hybridoma Bank (MPIIIB10, 1:20), and secondary antibody obtained from Sigma (#A9044, 1:1000). OPN immunoreactivity was visualized using a chemiluminescence detection system (Pierce) and densitometry performed using an Alpha-Innotech densitometer with AlphImager V5.5 software.
Additional lanes loaded with pre-stained protein standards (Bio-Rad) allowed determination of molecular weight.
Quantification of atherosclerosis in the aortic sinus. We have described this method in detail previously 12 . Briefly, aortic roots were frozen in tissue freezing medium, then cryocut at 8 μm intervals from the start of the aortic sinus, through the orifices of the coronary arteries, and to the origin of the ascending aorta. All sections were collected, stained with hematoxylin, and quantified for atherosclerosis using image analysis software. The area of the lesion is defined by the internal elastic lamina and the luminal boundary, and data are presented as the total lesion area in the number of sections quantified.
Statistical Analysis. Results are expressed as mean ± SEM unless otherwise noted. Differences between 2 groups were analyzed by Student's t-test, and differences between multiple groups were analyzed by one-way ANOVA followed by Bonferroni t-testing. defined by the internal elastic lamina and the luminal boundary, and data are presented as the total lesion area (mm 2 ), as described in Materials and Methods (available online at http://atvb.ahajournals.org). No statistically significant differences were detected between control (n=4), ANGII (n=9), and ANGII + vitE (n=9) groups.
